The Added Value of a Multidisciplinary Clinic for Systemic Autoinflammatory Diseases

被引:1
|
作者
Zinterl, Carolina [1 ,2 ,3 ]
Costa-Reis, Patricia [1 ,4 ,5 ]
Esteves, Isabel Castro [5 ]
Marques, Jose Goncalo [5 ]
Sousa, Ana Berta [5 ,6 ]
Fonseca, Joao Eurico [2 ,3 ]
Ramos, Filipa Oliveira [1 ,2 ,3 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Ctr Acad Med Lisboa, Pediat Rheumatol Unit, Lisbon, Portugal
[2] Univ Lisbon, Ctr Acad Med Lisboa, Fac Med, Inst Med Mol, Lisbon, Portugal
[3] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Ctr Acad Med Lisboa, Rheumatol Dept, Lisbon, Portugal
[4] Univ Lisbon, Ctr Acad Med Lisboa, Fac Med, Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Ctr Acad Med Lisboa, Pediat Dept, Lisbon, Portugal
[6] Univ Lisbon, Ctr Acad Med Lisboa, Fac Med, Dept Basic Immunol, Lisbon, Portugal
关键词
pediatrics; rheumatology; systemic autoinflammatory syndromes; RECURRENT FEVER; MOSAICISM; REUMA.PT; R92Q;
D O I
10.2147/JMDH.S351546
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Systemic autoinflammatory diseases (SAID) are characterized by inappropriate activation of the innate immune system and include not only monogenic periodic fever syndromes but also multifactorial conditions. As SAID are rare and represent a diagnostic challenge, a multidisciplinary approach is important to ensure successful diagnosis and adequate follow-up of these patients. Objective: To describe the organization of our multidisciplinary SAID clinic and to characterize our clinical experience, highlighting the benefits of multidisciplinary team management. Methods: Our SAID clinic takes place monthly and is managed by pediatric rheumatologists closely collaborating with pediatricians specialized in infectious diseases and immunodeficiencies and one medical geneticist. Patients' data are systematically incorporated in the Rheumatic Diseases Portuguese Register (Reuma.pt). Biological samples are stored in a biobank. We describe our clinical experience based on SAID patients registered into Reuma.pt/SAID between July 2011 and June 2020. Results: We have registered 176 patients, with a median age of disease onset of 3.1 +/- 4.4 years and median age at disease diagnosis of 4.7 +/- 4.0 years. Most patients were diagnosed with periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome (PFAPA) (n=133), 20 with undefined SAID (uSAID) and 13 with monogenic SAID, including familial Mediterranean fever (FMF) (n=5), tumor necrosis factor receptor-associated periodic syndrome (TRAPS) (n=1), cryopyrin-associated periodic disease (CAPS) (n=1), and hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) (n=2). A genetic test was performed in 31 patients (18%), and in 26% of these a mutation responsible for the phenotype was found. Thirty-four patients (19%) achieved remission. Conclusion: FMF was the most common monogenic SAID and the percentage of patients with an identified causal mutation was low. A structured electronic clinical record coupled with a biobank and a multidisciplinary approach are crucial to ensure successful diagnosis and adequate follow-up of these patients.
引用
收藏
页码:999 / 1010
页数:12
相关论文
共 50 条
  • [41] Autoinflammatory diseases
    Grateau, G.
    REVUE DE MEDECINE INTERNE, 2018, 39 (04): : 211 - 213
  • [42] Autoinflammatory diseases
    Russo, Ricardo A. G.
    Katsicas, Maria M.
    MEDICINA-BUENOS AIRES, 2016, 76 (03) : 166 - 172
  • [43] Autoinflammatory Diseases
    Blank, N.
    Huppertz, H. -I.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (07): : 609 - 610
  • [44] Autoinflammatory diseases
    Touitou, Isabelle
    Kone-Paut, Isabelle
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (05): : 811 - 829
  • [45] Immunology in clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation
    Mankan, A. K.
    Kubarenko, A.
    Hornung, V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (03): : 369 - 381
  • [46] Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases
    Ferhat Demir
    Özlem Akgün Doğan
    Yasemin Kendir Demirkol
    Kübra Ermiş Tekkuş
    Sezin Canbek
    Şerife Gül Karadağ
    Hafize Emine Sönmez
    Nuray Aktay Ayaz
    Hamdi Levent Doğanay
    Betül Sözeri
    Clinical Rheumatology, 2020, 39 : 3733 - 3745
  • [47] Gene Therapy for IL1-Mediated Systemic Autoinflammatory Diseases
    Colantuoni, Mariasilvia
    Hernandez, Raisa Jofra
    Pettinato, Emanuela
    Zoccolillo, Matteo
    Basso-Ricci, Luca
    Scala, Serena
    Sergi, Lucia Sergi
    Kajaste-Rudnitski, Anna
    Naldini, Luigi
    Aiuti, Alessandro
    Mortellaro, Alessandra
    MOLECULAR THERAPY, 2021, 29 (04) : 349 - 349
  • [48] Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases
    Demir, Ferhat
    Dogan, Ozlem Akgun
    Demirkol, Yasemin Kendir
    Tekkus, Kubra Ermis
    Canbek, Sezin
    Karadag, Serife Gul
    Sonmez, Hafize Emine
    Ayaz, Nuray Aktay
    Doganay, Hamdi Levent
    Sozeri, Betul
    CLINICAL RHEUMATOLOGY, 2020, 39 (12) : 3733 - 3745
  • [49] HISTORY OF ABORTION AND MULTIPARITY IN SYSTEMIC AUTOIMMUNE DISEASES: RESULTS FROM A MULTIDISCIPLINARY PREGNANCY CLINIC (GYNECOLOGY, RHEUMATOLOGY AND NEPHROLOGY)
    Sieiro Santos, C.
    Park, H.
    Magallares, B.
    Marco, H.
    Llurba, E.
    Diaz, M.
    Ros, S.
    Moya, P.
    Tandaipan, J. L.
    Diaz-Torne, C.
    Pitarch, C.
    Fernandez-Sanchez, S. P.
    Laiz, A.
    Torguet, J.
    Codes, H.
    Castellvi, I.
    Corominas, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1543 - 1544
  • [50] Time for a new approach to drug development for rare systemic autoinflammatory diseases
    Zitoun, Natalie M.
    Demirkaya, Erkan
    Goldbach-Mansky, Raphaela
    Romano, Micol
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (06) : 317 - 318